About GIST Cancer Research Fund
The GIST Cancer Research Fund (GCRF) was established in 2001 for the purpose of supporting and encouraging research on gastrointestinal stromal tumors (GIST), which belong to a group of cancers known as soft tissue sarcomas. GCRF also provides information on GIST and helps newly diagnosed patients learn about resources available to them. The number of new cases of GIST in the United States annually is estimated to be 5,000 to 6,000. Gastrointestinal stromal tumors arise in the intestinal tract, with the most common site being the stomach. GCRF provides information on GIST to patients, family members, the general public and the medical community. It conducts fundraising activities to support research related to the diagnosis and treatment of GIST. Other services include support groups and patient networking.